Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (13)
P 3 (1)

Trial Status

Recruiting8
Not Yet Recruiting6
Completed5
Active Not Recruiting1
Enrolling By Invitation1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT07236450Not ApplicableCompletedPrimary

Use of a Mobile Application for Tracking Physical Activity in the Management of Metabolic Syndrome in Primary Care

NCT07269847Not ApplicableRecruitingPrimary

Comparing a Healthy Beef-Centric Diet to a Healthy U.S.-Style Diet on Metabolic Health Outcomes in Pre-Diabetic Adults

NCT06992453Not ApplicableNot Yet Recruiting

Multi-omics Dissection of Gut Microbiome Engraftment During FMT

NCT06946472Not Yet Recruiting

Impact of Metabolic Syndrome on Rehabilitation Outcomes in Rotator Cuff Injury

NCT07533513Not ApplicableNot Yet RecruitingPrimary

Effects and Mechanisms of Dietary Carbohydrate Intake and Quality on Glucose and Lipid Metabolism

NCT07329088Not ApplicableWithdrawn

Isoleucine Addition Treatment Effects in a Controlled Diet Study

NCT07410325Not ApplicableRecruitingPrimary

Effectiveness and Implementation of a Community-based Health Coach-led Artificial Intelligence (AI)-Powered Digital Self-Regulation Program for Individuals With Metabolic Syndrome (MetS)

NCT06940375Recruiting

Incidence of Liver Disease-Related Outcomes in People With HIV

NCT07219602Phase 3Recruiting

A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome

NCT07462104Not Yet RecruitingPrimary

Metabolic Syndrome Associated Diet

NCT07180147Active Not Recruiting

Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

NCT07426172Not ApplicableRecruiting

Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism.

NCT07390422Not ApplicableNot Yet Recruiting

Duodenal ReCET for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease

NCT07354815Not Yet RecruitingPrimary

Metabolic Syndrome-Associated Periodontal Inflammatory Surface Area

NCT07314177Not ApplicableCompleted

Effects of Three Dietary Strategies on Body Composition and Metabolic Health in Adults With Overweight or Obesity

NCT07096102Not ApplicableRecruitingPrimary

Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome

NCT07248371RecruitingPrimary

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

NCT07085923Not ApplicableRecruiting

Norwegian Mental Illness Heart Health Study

NCT07183137CompletedPrimary

Metabolic Surgery for Metabolic Syndrome

NCT07164014Not ApplicableCompletedPrimary

The Impact of the Mediterranean Diet on Anthropometric Indices, Lipid Profiles, Energy Metabolism Signaling Proteins and Inflammatory Cytokines in Psychiatric Patients With Metabolic Syndrome

Scroll to load more

Research Network

Activity Timeline